Thank you for that post..... I should have thought about this with the other two companies I owned in the past.... New drug, very promisings, new headquarters, hopes hight.... Then, Boom!! Gone!
There is no way to know if Bavi was any good. It should have been in 100s of trials 10 years ago. PS is definitely a target but I don't think Bavi has been explored in depth. Problem is there probably is not enough patent time for BP to pay up to explore Bavi. Now betabodies may be a different story.
News 
Market Data 
Discover 
AI
